Ironwood Pharmaceuticals Inc (IRWD) Stock Forecast & Predictions

Ironwood Pharmaceuticals Inc - Class A IRWD: $10.81

100 Summer St Ste 2300, Boston, Massachusetts, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: https://www.ironwoodpharma.com/

  • Market Cap$1.75B
  • Change (52 Weeks)9.10%
  • Low (52 Weeks)$8.63
  • Ironwood Pharmaceuticals Inc (IRWD) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 12.50% are on Buy, 37.50% on Sell, and 50.00% Neutral.

    According to the market data, Ironwood Pharmaceuticals Inc (IRWD) stock price is $10.81 and the 52 weeks low is $8.63, which means the Ironwood Pharmaceuticals Inc stock price is up 9.10% in the last 12 months.

    Ironwood Pharmaceuticals Inc (IRWD) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 12.50% are indicating that IRWD Stock price might rise further, 37.50% indicating that IRWD Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall IRWD stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Ironwood Pharmaceuticals Inc (IRWD) Stock Forecast By Analysts


    On Hold
    Analysts Recommendations for Ironwood Pharmaceuticals Inc (IRWD) is based on 12 Institutional Analyst Ratings where 33.33% are on Strong Buy, 16.67% on Moderate Buy, 50.00% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 12 Institutional Analysts, majority recommended IRWD stock as On Hold. This means investors are recommended to hold their existing positions if any, otherwise, the recommendation is neither to buy nor sell at this stage. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Ironwood Pharmaceuticals Inc.

    Ironwood Pharmaceuticals Inc (IRWD) Stock Price Prediction By Analysts


    HighLowAverage
    $21.00$9.09$12.53
    $12.5315.92% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for IRWD set by the institutional analysts is $12.53 where High Estimate is $21.00, Median $11.22 and Low $9.09.

    The average price target for IRWD by Institutional Analysts is $12.53, which is 15.92% Upside from the current price. So according to the Institutional Analysts, IRWD Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Ironwood Pharmaceuticals Inc (IRWD) Stock Forecast Based on News Sentiment


    Neutral
    Based on 2 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of IRWD consisting of positive and negative, it shows that Ironwood Pharmaceuticals Inc had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so IRWD stock price most likey won't have any reaction to last weeks news coverage.

    Ironwood Pharmaceuticals Inc (IRWD) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    Credit SuisseNeutralMaintained
    Wells FargoEqual-WeightDowngraded
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    Credit SuisseNeutralMaintained
    HC Wainwright & Co.NeutralReiterated
    Morgan StanleyEqual-WeightMaintained
    Wells FargoOverweightMaintained
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightUpgraded
    H.C. WainwrightNeutralUpgraded
    JP MorganNeutralUpgraded
    JP MorganUnderweightDowngraded
    Credit SuisseNeutralDowngraded
    Wells FargoOutperformMaintained
    H.C. WainwrightSellInitiated
    Cowen & Co.Market PerformDowngraded
    Wells FargoOutperformMaintained
    Morgan StanleyUnderweightDowngraded
    BarclaysEqual-WeightMaintained
    MizuhoBuyUpgraded
    Bank of AmericaUnderperformDowngraded
    MizuhoNeutralDowngraded
    Credit SuisseOutperformInitiated
    JP MorganNeutralDowngraded
    Wells FargoOutperformInitiated
    JP MorganOverweightMaintained
    BarclaysEqual-WeightMaintained
    Cowen & Co.OutperformUpgraded
    Goldman SachsNeutralInitiated
    BarclaysEqual-WeightMaintained
    MizuhoBuyInitiated
    BTIG ResearchBuyInitiated
    Leerink SwannMarket PerformMaintained
    JP MorganOverweightMaintained
    Bank of AmericaBuyInitiated
    BarclaysEqual-WeightInitiated
    JP MorganOverweightMaintained
    Cantor FitzgeraldHoldUpgraded
    JP MorganOverweightMaintained
    Cantor FitzgeraldSellDowngraded
    Cowen & Co.Market PerformDowngraded
    Leerink SwannMarket PerformMaintained
    Furey ResearchBuyInitiated
    WallachbethHoldInitiated
    Leerink SwannMarket PerformMaintained
    JP MorganOverweightMaintained
    Cantor FitzgeraldHoldMaintained
    Cowen & Co.OutperformUpgraded
    Leerink SwannMarket PerformInitiated
    BMO CapitalMarket PerformInitiated
    Goldman SachsSellInitiated
    JefferiesHoldMaintained
    Janney CapitalBuyUpgraded
    Cantor FitzgeraldHoldUpgraded
    Credit SuisseOutperformInitiated
    WedbushNeutralUpgraded
    Cowen & Co.NeutralDowngraded
    WedbushUnderperformDowngraded
    Morgan StanleyEqual-WeightDowngraded
    Aegis CapitalBuyMaintained
    Credit SuisseOutperformUpgraded
    Bank of AmericaNeutralMaintained
    WedbushNeutralUpgraded
    Janney CapitalNeutralInitiated
    UBSSellDowngraded
    JP MorganOverweightMaintained
    Aegis CapitalBuyMaintained
    Cantor FitzgeraldSellMaintained
    MizuhoBuyInitiated
    Aegis CapitalBuyMaintained
    Cantor FitzgeraldSellMaintained
    Cantor FitzgeraldSellMaintained
    Aegis CapitalBuyInitiated
    Bank of AmericaNeutralMaintained
    Ladenburg ThalmannBuyMaintained
    UBSNeutralInitiated
    WedbushUnderperformDowngraded
    Cantor FitzgeraldSellDowngraded

    Ironwood Pharmaceuticals Inc (IRWD) Stock Earning Per Share (EPS) Forecast / Estimate


    $0.218
    The average consensus EPS for IRWD is $0.218 with a high estimate of $0.263 and Low of $0.167 for the period 2021-06-30 and based on 8 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $0.23$0.155042020-09-30


    The latest average Earning Per Share Estimate for Ironwood Pharmaceuticals Inc is $0.22, which is lower than IRWD's last EPS, $0.23. This means that Analysts are expecting Ironwood Pharmaceuticals Inc to report lower earnings. This can drive share prices lower since the investors have negative sentiment about market performance of Ironwood Pharmaceuticals Inc.

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $0.23$0.155042020-09-30
    $0.16$0.089759999999999992020-06-30
    $0.04$0.0510000000000000042020-03-31
    $0.3$0.24115862019-12-31
    $0.4$0.11365862019-09-30
    $0.1$-0.02928422019-06-30
    $-0.26$-0.13828142019-03-31
    $-0.02$-0.150817199999999982018-12-31
    $-0.38$-0.17456282018-09-30
    $-0.28$-0.212162018-06-30
    $-0.27$-0.23167262018-03-31
    $-0.14$-0.18593582017-12-31
    $-0.18$-0.22610342017-09-30
    $-0.3$-0.22254362017-06-30
    $-0.36$-0.20771282017-03-31
    $-0.09$-0.24294362016-12-31
    $-0.23$-0.2392412016-09-30
    $-0.14$-0.15578462016-06-30
    $-0.09$-0.1372412016-03-31
    $-0.09$-0.170340000000000022015-12-31
    $-0.25$-0.200175000000000022015-09-30
    $-0.34$-0.221003400000000022015-06-30
    $-0.24$-0.231540000000000022015-03-31
    $-0.27$-0.21466922014-12-31
    $-0.3$-0.32642014-09-30
    $-0.44$-0.36759782014-06-30
    $-0.38$-0.44342462014-03-31
    $-0.43$-0.5112752013-12-31
    $-0.51$-0.58271582013-09-30
    $-0.57$-0.69281460000000012013-06-30
    $-0.82$-0.64915862013-03-31
    $-0.41$-0.478553399999999962012-12-31
    $0.42$0.12945842012-09-30
    $-0.38$-0.32300342012-06-30
    $-0.34$-0.24027122012-03-31
    $-0.07$-0.11405642011-12-31
    $-0.21$-0.210629999999999982011-09-30
    $-0.19$-0.18942422011-06-30
    $-0.19$-0.173400000000000032011-03-31
    $-0.12$-0.14792010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).